MoonLake Immunotherapeutics (MLTX) — Defensive Interval Ratio
MoonLake Immunotherapeutics (MLTX) has a Defensive Interval Ratio of 516 days as of December 2025. Defensive assets of $64.32 Million (cash $-, short-term investments $59.45 Million, receivables $4.87 Million) cover 516 days of daily cash needs of $124.60K/day. Check MoonLake Immunotherapeutics tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
MoonLake Immunotherapeutics Defensive Interval Ratio (2021–2025)
This chart shows how MoonLake Immunotherapeutics's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 516 days, meaning defensive assets of $64.32 Million can fund 516 days of operations without new revenue. Also explore net asset momentum of MoonLake Immunotherapeutics to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for MoonLake Immunotherapeutics (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for MoonLake Immunotherapeutics from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MoonLake Immunotherapeutics market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 516 days | $64.32 Million | $124.60K/day | $- | $59.45 Million | ▼ -3878 days |
| 2024 | 4394 days | $270.44 Million | $61.54K/day | $- | $267.60 Million | ▲ +2164 days |
| 2023 | 2230 days | $60.90 Million | $27.30K/day | $- | $59.84 Million | ▲ +667 days |
| 2022 | 1563 days | $32.83 Million | $21.00K/day | $- | $32.61 Million | ▲ +1560 days |
| 2021 | 3 days | $148.77K | $57.77K/day | $- | $0.00 | — |